Ralph D'Agostino to F2-Isoprostanes
This is a "connection" page, showing publications Ralph D'Agostino has written about F2-Isoprostanes.
Connection Strength
0.850
-
Il'yasova D, Wagenknecht LE, Spasojevic I, Watkins S, Bowden D, Wang F, D'Agostino RB. Urinary F2-isoprostanes and metabolic markers of fat oxidation. Oxid Med Cell Longev. 2015; 2015:729191.
Score: 0.498
-
Melton CD, Luo R, Wong BJ, Spasojevic I, Wagenknecht LE, D'Agostino RB, Il'yasova D. Urinary F2-isoprostanes and the risk of hypertension. Ann Epidemiol. 2017 06; 27(6):391-396.
Score: 0.145
-
Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring). 2012 Oct; 20(10):2147-50.
Score: 0.103
-
Siamakpour-Reihani S, Scarbrough PM, Wang F, Spasojevic I, Base K, Sedjo R, D'Agostino RB, Il'yasova D. Systemic markers of oxidative status and colorectal adenomatous polyps. Ann Epidemiol. 2012 Aug; 22(8):587-91.
Score: 0.103